Shingrix shingles vaccine now available at all Wegmans
Wegmans Food Market pharmacies on Monday announced that GSK’s Shingrix, the new, more effective shingles vaccine recently recommended by The Centers for Disease Control and Prevention, is now available chainwide.
“We want to help our customers stay healthy by providing easy, convenient access to the most effective vaccinations available,” Katie Niles, Wegmans pharmacist and pharmacy clinical wellness services manager, said. “Because Shingrix has a much higher rate of effectiveness, it is recommended that all adults 50 and older, including those who received the previously available vaccine, receive the Shingrix vaccine to reduce their risk.”
The CDC recommends that healthy adults 50 years and older get two doses of Shingrix, separated by two to six months, to protect against shingles and postherpetic neuralgia, the most common complication from shingles.
Approved by the U.S. Food and Drug Administration in October 2017, Shingrix is now the preferred shingles vaccine with an effective rate of more than 90% for the prevention of shingles and PHN, compared to the previously recommended vaccine, Zostavax, that reduced the risk of shingles and PHN by 51% and 67%, respectively, Wegmans reported.
The CDC’s recommendation of Shingrix means approximately 42 million adults aged 50-59 years old and 20 million who have previously been vaccinated against shingles may be eligible to receive the new vaccination.
Shingles is caused by the reactivation of the same virus that causes chickenpox, which remains dormant in the body after recovery. Anyone who has recovered from chickenpox can get shingles, though the risk increases with age. According to the CDC, almost one out of every three people in the U.S. will develop shingles in their lifetime, with an estimated one million cases of shingles each year.
Wegmans pharmacists are available to speak with customers and answer questions about the shingles vaccination and assist with determining their insurance policy’s coverage.
In addition to the shingles vaccine, Wegmans Pharmacy locations throughout the company’s six-state footprint offer an array of immunizations. Depending upon the state, customers may receive immunizations against influenza, hepatitis A, hepatitis B, varicella (chicken pox), human papillomavirus (HPV), MMR (measles, mumps and rubella), meningococcal (meningitis), pneumococcal disease (pneumonia), tetanus, diphtheria and pertussis.
CARE Pharmacies names two new board members
CARE Pharmacies Cooperative on Monday named Christine Lee-Wilson and Avani Sheth to the cooperative’s 2018 board of directors.
“Our Board of Directors is certainly privileged to have the addition of these two dynamic and influential store owners and clinicians,” Mike Wysong, CEO of the Linthicum, Md.-based CARE Pharmacies, said. “Avani and Christine both bring many years of distinguished service to our team and their experience and insight will be invaluable to CARE as we look for new ways to serve our customers well.”
Both appointees are registered pharmacists and own and operate successful community retail and specialty pharmacies.
Lee-Wilson holds a coctor of pharmacy degree from St. Johns University, New York, and recently served as the chair and president for the Maryland Pharmacists Association. She currently owns Professional Pharmacy in Baltimore.
Sheth holds a B.S. degree in pharmacy from Long Island University and currently oversees the compliance and accreditation functions at Giannotto’s Specialty Pharmacy in Newark, N.J.
CARE Pharmacies is a member-owned cooperative of independent community and specialty pharmacies offering a full range of programs and services designed to meet the dynamic needs of the independent pharmacy owner operator. Recognized by the National Retail Federation as one of the fastest growing retailers in the country, CARE has more than 80 locations in 15 states including the District of Columbia.
Walmart sets the stage for e-commerce growth
Walmart’s online results for the fourth quarter spooked investors, but the discounter is confident that it will regain momentum this year.
Walmart reported a 23% increase in online sales for the quarter, compared to a 50% increase in the previous quarter. The chain said part of the decline was expected as sales growth on Jet.com, which it acquired in 2016, cooled. It also cited operational snags.
Despite the disappointing results, Walmart is well poised for future online growth and expects e-commerce growth of 40% in its current fiscal year. It is planning a number of investments in its website and overall digital operations that should start to take hold later this year, CNBC reported.
The upcoming initiatives include a revamped website with a focus on fashion and home goods. The site will also feature Jet.com’s “smart cart” technology, which provides shoppers cheaper prices if they pack more items together in one box, use a debit card when paying for purchases or opt out of returns, the report said.
To read more, click here.